Ocrelizumab (Ocrevus): the treatment that slows multiple sclerosis
Ocrelizumab (Ocrevus) is a new therapy capable of slowing down the evolution of primary progressive multiple sclerosis and active forms of multiple sclerosis in outbreaks. Read More →